These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 21679198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation.
    Raasch H, Jensen BC, Chang PP, Mounsey JP, Gehi AK, Chung EH, Sheridan BC, Bowen A, Katz JN.
    Am Heart J; 2012 Sep; 164(3):373-8. PubMed ID: 22980304
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation.
    Salzberg SP, Lachat ML, Zünd G, Turina MI.
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):444-6. PubMed ID: 15296915
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Placement of a continuous-flow ventricular assist device in the failing ventricle of an adult patient with complex cyanotic congenital heart disease.
    Morris CD, Gregoric ID, Cooley DA, Cohn WE, Loyalka P, Frazier OH.
    Heart Surg Forum; 2008 Aug; 11(3):E143-4. PubMed ID: 18583283
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH, HeartMate II Investigators.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):312-21. PubMed ID: 19608028
    [Abstract] [Full Text] [Related]

  • 10. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD.
    J Am Coll Cardiol; 2011 May 10; 57(19):1890-8. PubMed ID: 21545946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.
    Ann Thorac Surg; 2008 Oct 10; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [Abstract] [Full Text] [Related]

  • 14. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices.
    Thohan V, Stetson SJ, Nagueh SF, Rivas-Gotz C, Koerner MM, Lafuente JA, Loebe M, Noon GP, Torre-Amione G.
    J Heart Lung Transplant; 2005 May 10; 24(5):566-75. PubMed ID: 15896754
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S, Barbone A, Reiken S, Holmes JW, Naka Y, Oz MC, Marks AR, Burkhoff D.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):668-76. PubMed ID: 15734609
    [Abstract] [Full Text] [Related]

  • 16. Ventricular fibrillation in an ambulatory patient supported by a left ventricular assist device: highlighting the ICD controversy.
    Boilson BA, Durham LA, Park SJ.
    ASAIO J; 2012 Mar 01; 58(2):170-3. PubMed ID: 22370689
    [Abstract] [Full Text] [Related]

  • 17. Improved left ventricular unloading and circulatory support with synchronized pulsatile left ventricular assistance compared with continuous-flow left ventricular assistance in an acute porcine left ventricular failure model.
    Letsou GV, Pate TD, Gohean JR, Kurusz M, Longoria RG, Kaiser L, Smalling RW.
    J Thorac Cardiovasc Surg; 2010 Nov 01; 140(5):1181-8. PubMed ID: 20546799
    [Abstract] [Full Text] [Related]

  • 18. Differential exercise performance on ventricular assist device support.
    Simon MA, Kormos RL, Gorcsan J, Dohi K, Winowich S, Stanford E, Carozza L, Murali S.
    J Heart Lung Transplant; 2005 Oct 01; 24(10):1506-12. PubMed ID: 16210122
    [Abstract] [Full Text] [Related]

  • 19. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, Moazami N.
    Ann Thorac Surg; 2010 Oct 01; 90(4):1270-7. PubMed ID: 20868826
    [Abstract] [Full Text] [Related]

  • 20. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ, Rogers JG, Blue L, Gallagher C, Russell SD, Dordunoo D, Jaski BE, Chillcott S, Sun B, Yanssens TL, Tatooles A, Koundakjian L, Farrar DJ, Slaughter MS.
    J Heart Lung Transplant; 2012 Jan 01; 31(1):27-36. PubMed ID: 22153550
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.